1.
Braz. j. infect. dis
;
12(4): 263-263, Aug. 2008.
Artículo
en Inglés
| LILACS
| ID: lil-496761
RESUMEN
Hyperamylasemia is a common complication during lamivudine use. We report a case of a pancreatitis following lamivudine therapy. A careful monitoring of amylase levels during treatment with lamivudine is discussed, mainly in the first weeks, considering the cost of this exam and further complication.